Corticotropin releasing hormone (CRH) is a key hormone in integrated response to stress, acting as the major regulator of the hypothalamic-pituitary-adrenal axis. Recently, local production of CRH has been detected in normal human colonic enterochromaffin cells. CRH is locally secreted in granulomatous and arthritic tissues in rats and humans, where it seems to act as a local proinflammatory agent. (Gut 1995; 37: 544-551) 
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To find out if CRH is present in colonic tissues of patients with ulcerative colitis, this study examined the expression of this peptide in the large bowel of patients with ulcerative colitis. Colonic tissues of patients with ulcerative colitis obtained by endoscopic biopsy were immunostained with anti-CRH antibody. CRH messenger (m) RNA was also examined in biopsy specimens of ulcerative colitis by the reverse transcribed polymerase chain reaction method and by in situ hybridisation. Considerably 19 Characteristics of this antibody used was: titre, 1:96000; dilution that causes 10% displacement of radiolabelled tracer, effective dose90 40 pg/ml; concentration that causes 50% displacement of radiolabelled tracer, effective dose50 170 pgfml. The anti-CRH antiserum has cross reactivity of less than 0-001% for growth hormone releasing hormone, luteinising hormone releasing hormone, antidiuretic hormone, ACTH, luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone, prolactin, ,B-endorphin, and growth hormone. Antihuman pan-macrophage antibody (Ki-M1)32 for double antibody immunostaining was purchased from Seikagaku Corporation, Tokyo, Japan. This antibody was secreted by a hybridoma formed from the fusion of mouse myeloma cells from BALB/C mouse immunised against human macrophages.
Immunohistochemistry
Tissue immunohistochemical staining was done with the Vectastain avidin-biotin peroxidase complex kit (Vector Laboratories, Burlingame, CA, USA). Colonic tissue specimens from 10 ulcerative colitis patients and 10 control subjects were preserved in 1 0% formalin. Specimens were embedded in paraffin wax, serially sectioned onto microscope slides at a thickness of 4 ,um, and then deparaffinised. The slides were immersed for 45 minutes in 0.3% hydrogen peroxide in methanol to deplete endogenous peroxidase. Non-specific binding sites were saturated with 0.3% bovine serum albumin, normal goat serum diluted to 1:66.7 in phosphate buffered saline for 20 minutes. Primary antibodies against CRH (affinity purified anti-CRH immunoglobulin G (IgG), 30 ,ug/ml), or control normal rabbit IgG (Vector) applied to tissue sections and incubated in a humidified chamber at a room temperature for 30 minutes. The sections were then washed with phosphate buffered saline for 10 minutes. Biotinylated goat antirabbit IgG (Vector) in 10 ml of phosphate buffered saline were applied to tissue sections, and the slides were incubated at room temperature for 30 minutes. They were further washed with phosphate buffered saline for 10 minutes. This was followed by incubation with performed avidin DH-biotinylated peroxidase (Vector) for 45 minutes, and followed by phosphate buffered saline for 10 minutes. Finally, colour was developed by immersion of the sections in a peroxidase substrate solution (0.05% 3,3'-diaminobenzidine tetrahydrochloride, 0.04% nickel chloride, and 0.01% hydrogen peroxide in 0.05 M TRIS-HCI (pH 7.2)) for two to five minutes. The sections were counterstained with 0.5% light green (Sigma Chemical, St Louis, MO, USA). Positive staining was shown by brownish-black deposits, and background staining was light green.
For each of the tissue specimens, the extent and intensity of staining with anti-CRH antibody in mucosal inflammatory cells were graded on a scale of 0-4+ by two blinded observers on two separate occasions using coded slides as previously described.19 20 In situ hybridisation and autoradiography We analysed CRH mRNA by in situ hybridisation in biopsy specimens from three ulcerative colitis patients and three normal subjects. In ulcerative colitis patients, one specimen was obtained from ascending colon, one from descending colon, one from sigmoid colon, two from rectum. In normal subjects, one specimen was obtained from ascending colon, one from transverse colon, one from descending colon, one from sigmoid colon, one from rectum. In situ hybridisation was performed as described previously by us.30 Colonic tissue sections were embedded in paraffin wax and placed onto gelatin coated slides at a thickness of 4 ,um. The slides were then acetylated, rinsed in phosphate buffered saline, dehydrated in graded solutions of ethanol, and dried before hybridisation. Hybridisation was performed for 24 hours at 37°C using 1 X 106 cpm of 32P-labelled oligonucleotide probe. The slides were washed for one hour at 55°C in 0.2Xstandard saline citrate. After further washing, the slides were dehydrated in graded solutions of ethanol, air dried, and dipped into photographic emulsion. After exposure for 14 days at 4°C, the slides were developed in Kodak D 19 developer (Kodak, Rochester, NY, USA) for three minutes, rinsed in water, and fixed in Fixer (Naniwa Photochemical Supplies, Osaka, Japan) for three minutes. The slides were finally counterstained with haematoxylin. Tissue sections were incubated with RNase buffer containing 0.5% NaCl, 10 m TRIS-HCl buffer (pH 8-0, 1 mM EDTA), and 0.02% RNase (Sigma) at 37°C for 30 minutes before hybridisation and used as a negative control.
Results

CRH mRNA transcripts in ulcerative colitis
Recently, some studies have shown CRH mRNA in synovia from Lewis rats with adjutant induced arthritis and patients with rheumatoid arthritis.'8 19 Using a similar reverse transcribed PCR method, we detected the segments of cDNA corresponding to specific CRH mRNA extracted from biopsy specimens from ulcerative colitis patients and normal subjects. Amplification of cDNA with CRH primers used in this study predicted a fragment of 425 base pair (bp) in length. All 10 ulcerative colitis patients and 10 normal subjects expressed CRH mRNA in colonic mucosa by PCR method. We could detect the same size bands for CRH mRNA. Figure 1 shows representative data of a normal subject (lane 1) and an ulcerative colitis patient (lane 2). Negative controls, performed with no RNA (lane 3) or no reverse transcriptase (lane 4), yielded no detectable bands. Primers specific for human 3-actin generated the expected 541 bp in all ulcerative colitis patients and normal subjects (data not shown).
Immunohistochemistry
Colonic biopsy specimens from normal subjects and ulcerative colitis patients were evaluated for immunoreactive CRH with affinity purified anti-CRH IgG. In normal colonic tissues, immunoreactive CRH expressed in a few mucosal epithelial cells and monocyte (Fig 2(C) ). We found considerably enhanced expression of immunoreactive CR1i in mucosal inflammatory cells in all ulcerative colitis patients, but not in the mucosal nerve fibres and the plexus (Fig 2(A) ). Immunoreactive CRH of mucosal inflammatory cells was mainly distributed in mononuclear cells (Fig 2(B) ). (Fig 4(A) ). Control staining with normal rabbit IgG and BALB/C ascites fluid was uniformly negative (Fig 4 (B) ).
Staining with anti-CRH antibody/BALB/C ascites fluid showed only brownish-black deposits (data not shown). Staining with antimacrophage antibody/normal rabbit IgG showed only red deposits (Fig 4(C) ). These findings suggested that many of the intense staining of CRH positive inflammatory cells in the colonic tissues of ulcerative colitis were mucosal macrophages. Expression of CRH mRNA in ulcerative colitis To examine the localisation of CRH mRNA in colonic tissues of ulcerative colitis patients and normal subjects, we performed in situ hybridisation with 32P-labelled oligonucleotide probe. In all biopsy specimens of ulcerative colitis patients (five of five), CRH mRNA was expressed in the colonic mucosal epithelial Fig 4C   Figure 4 : Double antibody immunostaining with anti-CRH and antimacrophage antibody in same colon tissues of patients with ulcerative colitis. Sections were stained with antihuman pan-macrophage antibody using alkaline phosphatase method and anti-CRH antibody using peroxidase method (A), and stained with antimacrophage antibody using alkaline phosphatase method and normal rabbit IgG using peroxidase method (C). Counterstaining was done with 0O5% light green. Positive staining was shown by brownish-black deposits for the peroxidase method, red deposits for the alkaline phosphatase method, and black-red deposits for the double antibody staining. (Bar= 100 ,gm.) cells. CRH mRNA was localised to the mucosal layer. It was not detected in the submucosa, however, nor in the nerve fibres and plexus (Fig 5(A) ). In all biopsy specimens of normal subjects (five of five), CRH mRNA was expressed in normal colonic mucosal epithelial cells (data not shown). It was difficult to compare inflamed mucosa with normal mucosa, because the structure of mucosa of ulcerative colitis was destroyed by inflammation and ulceration. In our study, the expression of CRH mRNA in mucosal epithelial cells of ulcerative colitis was not significantly increased compared with that of normal subjects. Negative control hybridisation incubated with RNase buffer showed only a few background silver grains (Fig 5(B) ). 43 In ulcerative colitis, we could find CRH and CRH mRNA in colonic epithelial and inflammatory cells, but not in the mucosal or submucosal nerve fibres and plexus. There is also the possibility as to whether peripheral CRH in colonic mucosa may be able to influence the mucosal nervous system in ulcerative colitis.
Thus, it is very tempting to implicate CRH as an important mediator in the pathogenesis of ulcerative colitis. The mechanism of actions of peripheral CRH are multiple and not completely elucidated, and the specific roles for CRH in the inflammatory response in ulcerative colitis remain to be solved. This study suggests that CRH in the colonic mucosa may act as a proinflammatory agent modulating the intestinal immune system.
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